Giving Shingles Immunization Your Best Shot: Implementing a Shingles Vaccination Protocol in Your Practice

CMEO Webcast

Premiere Date: Wednesday, August 26, 2020

This activity offers CE credit for:

  1. Physicians (CME)
  2. Nurses (CNE)
  3. Pharmacists (ACPE)
  4. ABIM (MOC)
  5. Other


Credit Expiration Date: Thursday, August 26, 2021

Begin Activity Now

Faculty


William Schaffner, MD William Schaffner, MD (Moderator)
Professor of Preventive Medicine, Department of Health Policy
Professor of Medicine, Division of Infectious Diseases
Vanderbilt University School of Medicine
Nashville, TN

Anthony Cunningham, MD, MBBS Anthony Cunningham, MD, MBBS 
Director, Westmead Institute for Virus Research
Professor of Medicine and Health
University of Sydney Medical School
Director, Australian Centre for HIV and Hepatitis Virology Research (ACH2)
New South Wales / Australian Capital Territory State Branch Chair
Australian Academy of Health and Medical Sciences
Westmead, NSW
Australia

Iris Gorfinkel, MD, CM Iris Gorfinkel, MD, CM 
Founder and Principal Investigator
PrimeHealth Clinical Research
Toronto, ON
Canada

Statement of Need

Shingles, or herpes zoster, is a common secondary infection for older patients. Almost all individuals over the age of 50 are latently infected with varicella zoster virus (VZV) and therefore are at risk of developing shingles with reactivation of latent VZV. Individuals who develop shingles often experience debilitating postherpetic neuralgia (PHN), secondary skin infections, eye problems, or neurologic conditions including an increased risk of stroke.

Despite the existence of vaccines, the number of people vaccinated for shingles remains low. In large part, this is due to the majority of individuals being unaware that a vaccine exists, as clinicians often fail to initiate discussion about it.

This CME Outfitters Live and OnDemand webcast will focus on the burden imposed by shingles, improving uptake of vaccination and series completion for shingles through patient education, and applying real-world strategies to implement shingles immunization protocols.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Identify the primary risk factors and clinical and quality of life (QoL) complications imposed by shingles.
  • More frequently and effectively educate eligible patients about shingles vaccination to improve uptake of vaccination and series completion for shingles.
  • Apply real-world strategies to implement shingles immunization that consider safety and efficacy of available therapies, storage and administration, and pharmacy-based vaccination.

The following learning objectives pertain only to those requesting CNE or CPE credit:

  • Identify the primary risk factors and clinical and QoL complications imposed by shingles.
  • Explain ways to educate eligible patients about shingles vaccination to improve uptake of vaccination and series completion for shingles.
  • Summarize real-world strategies to implement shingles immunization that consider safety and efficacy of available therapies, storage and administration, and pharmacy-based vaccination.

Financial Support

This educational activity is supported by an educational grant from GlaxoSmithKline.

Target Audience

Physicians, PAs, nurse practitioners, nurses, and pharmacists

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.

Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

CPE Credit (Pharmacists):
ACPE CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs) Universal Activity Number:
Enduring: 0376-0000-20-110-H01-P

Type: Knowledge-based

ABIM/MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Learning Formats
Live activity
Enduring material

Royal College MOC: Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program.

MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Note to PAs: PAs may claim a maximum of 1.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-and-confidentiality-policy

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Schaffner has no disclosures to report.

Dr. Cunningham reports he is on the advisory committee for GlaxoSmithKline.

Dr. Gorfinkel reports she receives research support from GlaxoSmithKline and Merck & Co., Inc. She is on the advisory committee and consultant for GlaxoSmithKline.

Kashemi D. Rorie, PhD (planning committee) has no disclosures to report.

Jeffrey Helfand, DO (peer reviewer) has no disclosures to report.

Mae Ochoa, RPh (peer reviewer) has no disclosures to report.

Evan Luberger (planning committee) has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).


This document was last modified on:

TV-115-082620-06